Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6239)
All Articles published online
|
Publishing Process of This Article
|
Jun 7, 2014 (publication date) through Jan 11, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Aoyama T, Yoshikawa T, Fujikawa H, Hayashi T, Ogata T, Cho H, Yamada T, Hasegawa S, Tsuchida K, Yukawa N, Oshima T, Oba MS, Morita S, Rino Y, Masuda M. Prognostic factors in stage IB gastric cancer. World J Gastroenterol 2014; 20(21): 6580-6585 [PMID: 24914380 DOI: 10.3748/wjg.v20.i21.6580] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i21/6580.htm |
| Number | Citing Articles |
| 1 |
Tae-Min Kim, Seung-Hyun Jung, Min Sung Kim, In-Pyo Baek, Sung-Won Park, Sung Hak Lee, Han Hong Lee, Sung Soo Kim, Yeun-Jun Chung, Sug Hyung Lee. The mutational burdens and evolutionary ages of early gastric cancers are comparable to those of advanced gastric cancers. The Journal of Pathology 2014; 234(3): 365 doi: 10.1002/path.4401
|
| 2 |
M Tokunaga, S Ito, T Yoshikawa, S Nunobe, T Fukagawa, K Misawa, H Cho, H Katai, T Sano, M Terashima. Prognostic factors for survival in patients with pT1 N+ or T2–3 N0 gastric cancer in Japan. British Journal of Surgery 2017; 104(7): 885 doi: 10.1002/bjs.10509
|
| 3 |
Dingcheng Zheng, Bangsheng Chen, Zefeng Shen, Lihu Gu, Xianfa Wang, Xueqiang Ma, Ping Chen, Feiyan Mao, Zhiyan Wang. Prognostic factors in stage I gastric cancer: A retrospective analysis. Open Medicine 2020; 15(1): 754 doi: 10.1515/med-2020-0164
|
| 4 |
Yukimi Ohmori, Takashi Nomura, Norimasa Fukushima, Fumiaki Takahashi, Takeshi Iwaya, Keisuke Koeda, Satoshi S. Nishizuka. Recurrence risk evaluation in T1N1M0/T2N0M0/T3N0M0 gastric cancer with TP53 codon 72 polymorphisms. Journal of Surgical Oncology 2019; 120(7): 1154 doi: 10.1002/jso.25718
|
| 5 |
Kei Hosoda, Keishi Yamashita, Natsuya Katada, Hiromitsu Moriya, Hiroaki Mieno, Tomotaka Shibata, Shinichi Sakuramoto, Shiro Kikuchi, Masahiko Watanabe. Potential benefits of laparoscopy-assisted proximal gastrectomy with esophagogastrostomy for cT1 upper-third gastric cancer. Surgical Endoscopy 2016; 30(8): 3426 doi: 10.1007/s00464-015-4625-8
|
| 6 |
Chen Su, Zeyang Lin, Zhijian Ye, Jing Liang, Rong Yu, Zheng Wan, Jingjing Hou. Development of a prognostic model for early-stage gastric cancer-related DNA methylation-driven genes and analysis of immune landscape. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1455890
|
| 7 |
Zi-Jian Deng, Run-Cong Nie, Jun Lu, Xi-Jie Chen, Jun Xiang, Chang-Ming Huang, Ying-Bo Chen, Jun-Sheng Peng, Shi Chen. Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01937-9
|
| 8 |
Quan Xu, Wen-Zhe Kang, Jian-Ping Xiong, Xin-Xin Shao, Wei-Kun Li, Hai-Tao Hu, Yan-Tao Tian. A new scoring system to evaluate adjuvant chemotherapy for patients with T2N0M0 gastric cancer after D2 gastrectomy. World Journal of Gastroenterology 2022; 28(38): 5626-5635 doi: 10.3748/wjg.v28.i38.5626
|
| 9 |
Linda Agolli, Riccardo Maurizi Enrici, Mattia Falchetto Osti. Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?. World Journal of Gastroenterology 2016; 22(3): 1131-1138 doi: 10.3748/wjg.v22.i3.1131
|
| 10 |
Xi Liu, Xiaodong Wei, Wei Niu, Dong Wang, Bo Wang, Hao Zhuang. Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9466
|
| 11 |
Peng Jin, Xiaoyan Ji, Shuai Ma, Wenzhe Kang, Hao Liu, Yang Li, Fuhai Ma, Haitao Hu, Weikun Li, Yantao Tian. Indications for adjuvant chemotherapy in patients with pT1N1M0 gastric cancer: a single-center experience. Journal of Cancer Research and Clinical Oncology 2021; 147(2): 561 doi: 10.1007/s00432-020-03355-y
|
| 12 |
M.B. Rumyantseva, A.M. Avdalyan, A.A. Ivanov, D.N. Protsenko, T.N. Baklanova. The significance of the tumor microenvironment and molecular biological parameters in assessing the prognosis of the disease in patients with early-stage gastric cancer. Onkologiya. Zhurnal imeni P.A.Gertsena 2023; 12(4): 78 doi: 10.17116/onkolog20231204178
|
| 13 |
Mingyu Gu, Binghe Zhao, Changda Sui, Minghai Wen, Xinxin Wang. Is Adjuvant Therapy Necessary for Stage IB Gastric Cancer: A Retrospective Cohort Study. Annals of Surgical Oncology 2025; 32(2): 1210 doi: 10.1245/s10434-024-16444-w
|
| 14 |
Shengxian Fan, Min Feng, Meng Wang, Wenxian Guan. Extensive small bowel metastasis and peritoneal dissemination 1 year following curative gastrectomy for T1N1 gastric cancer. Medicine 2019; 98(5): e13984 doi: 10.1097/MD.0000000000013984
|
| 15 |
Y. Wang, J. Zhang, S. Guo, Z. Dong, X. Meng, G. Zheng, D. Yang, Z. Zheng, Y. Zhao. Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis. Clinical and Translational Oncology 2019; 21(11): 1499 doi: 10.1007/s12094-019-02078-y
|
| 16 |
Peng Jin, Xiaoyan Ji, Shuai Ma, Wenzhe Kang, Hao Liu, Yang Li, Fuhai Ma, Haitao Hu, Jianping Xiong, Yantao Tian. Adjuvant chemotherapy indications for stage I gastric cancer patients with negative lymph node. Clinics and Research in Hepatology and Gastroenterology 2021; 45(6): 101634 doi: 10.1016/j.clinre.2021.101634
|